Is the activity of kininase II (ACE; E.C. 3.4.15.1) influenced by beta-adrenergic factors?
D000818:Animals; D002216:Captopril / Q000494:pharmacology; D004727:Endothelium / Q000201:enzymology; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011941:Receptors, Adrenergic / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D013997:Time Factors
D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D002216:Captopril; D011433:Propranolol; D007703:Peptidyl-Dipeptidase A; D007545:Isoproterenol